ZNF79 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.407500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.057800E-01
Normal-vs-Stage2
1.346360E-02
Normal-vs-Stage3
1.368980E-01
Normal-vs-Stage4
3.995400E-01
Stage1-vs-Stage2
4.450200E-01
Stage1-vs-Stage3
2.978200E-01
Stage1-vs-Stage4
9.140000E-01
Stage2-vs-Stage3
2.828800E-01
Stage2-vs-Stage4
3.356400E-01
Stage3-vs-Stage4
2.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.901900E-02
Normal-vs-AfricanAmerican
1.912580E-01
Normal-vs-Asian
8.475600E-02
Caucasian-vs-AfricanAmerican
8.526800E-01
Caucasian-vs-Asian
8.000000E-01
AfricanAmerican-vs-Asian
9.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.029800E-02
Normal-vs-Female
6.458200E-02
Male-vs-Female
5.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.682000E-01
Normal-vs-Age(41-60Yrs)
9.666000E-02
Normal-vs-Age(61-80Yrs)
3.414200E-02
Normal-vs-Age(81-100Yrs)
1.162460E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.727600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.936000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.582200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.876210E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.080800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.959100E-03
Normal-vs-Daily Drinker
1.028250E-02
Normal-vs-Weekly Drinker
1.311160E-01
Normal-vs-Occasional Drinker
1.274770E-01
Normal-vs-Social Drinker
3.031400E-01
Non Drinker-vs-Daily Drinker
6.560600E-01
Non Drinker-vs-Weekly Drinker
2.181700E-02
Non Drinker-vs-Occasional Drinker
2.641600E-02
Non Drinker-vs-Social Drinker
8.401500E-04
Daily Drinker-vs-Weekly Drinker
7.650500E-02
Daily Drinker-vs-Occasional Drinker
9.306100E-02
Daily Drinker-vs-Social Drinker
6.056600E-03
Weekly Drinker-vs-Occasional Drinker
9.147800E-01
Weekly Drinker-vs-Social Drinker
3.555800E-01
Occasional Drinker-vs-Social Drinker
2.994200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.932600E-01
Normal-vs-Grade 2
8.142400E-01
Normal-vs-Grade 3
8.195800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.185600E-01
Grade 1-vs-Grade 3
3.146200E-01
Grade 1-vs-Grade 4
4.932600E-01
Grade 2-vs-Grade 3
9.221000E-01
Grade 2-vs-Grade 4
8.142400E-01
Grade 3-vs-Grade 4
8.195800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.272350E-02
Normal-vs-NonDiabetic
6.857900E-02
Diabetic-vs-NonDiabetic
1.933810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.033810E-01
Normal-vs-NoPancreatitis
4.976200E-02
Pancreatitis-vs-NoPancreatitis
8.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.380610E-01
Normal-vs-N1
1.577570E-02
N0-vs-N1
3.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.305800E-01
Normal-vs-TP53-NonMutant
2.845000E-01
TP53-Mutant-vs-TP53-NonMutant
1.984440E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
